Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
ME

NASDAQ · MEDS

TRxADE HEALTH, Inc.

Healthcare · Medical - Pharmaceuticals

$1.49

Down-$0.31 (-17.22%)

Updated Nov 5, 2026, 5:13 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
13.28M
P/E ratio
-6.94
Dividend yield
0.00%
52-week range
— – —
Volume
165.45K
Avg. volume
73.36K

Price performance · MEDS

MEDS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

MEDS closed at $1.49 after 21 trading sessions, down 48.26% for the selected period.

Last close
$1.49
Period change
-48.26%
Period low
$1.49
Period high
$3.40
Daily close
View OHLC price history
MEDS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$1.72$1.7799$1.4501$1.49165.45K
Nov 3, 2026$1.83$1.83$1.62$1.80187.28K
Nov 2, 2026$1.90$2.02$1.72$1.83494.87K
Oct 30, 2026$1.94$1.9775$1.86$1.92146.47K
Oct 29, 2026$2.23$2.23$1.98$2.03227.86K
Oct 28, 2026$2.02$2.27$2.00$2.20347.47K
Oct 27, 2026$2.06$2.08$1.97$2.06360.32K
Oct 26, 2026$2.24$2.29$2.13$2.19617.52K
Oct 23, 2026$2.33$2.37$2.14$2.23376.47K
Oct 22, 2026$2.65$2.6895$2.25$2.30911.65K
Oct 21, 2026$2.70$2.7714$2.57$2.72209.88K
Oct 20, 2026$2.62$2.7799$2.5801$2.75450.79K
Oct 19, 2026$3.03$3.08$2.56$2.674.14M
Oct 16, 2026$2.80$2.86$2.6201$2.63309.46K
Oct 15, 2026$2.71$2.876$2.65$2.85255.61K
Oct 14, 2026$2.90$3.04$2.80$2.85672.5K
Oct 13, 2026$2.95$3.15$2.941$3.03867.31K
Oct 12, 2026$3.31$3.80$3.00$3.0721.21M
Oct 9, 2026$3.16$3.30$2.9512$2.96482.2K
Oct 8, 2026$3.13$3.70$2.88$3.4014.06M
Oct 7, 2026$3.10$3.13$2.84$2.88363.49K

Latest MEDS news

The latest Smart Investors Daily articles mentioning MEDS.

Stock researchCompany · Overview

MEDS research

Overview

Company profile and research snapshot.

Company profile

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.89
Implied upside
—
Analysts
—
MEDS recent ratings
DateFirmRatingTarget
May 16, 2023EF HuttonBuy—
Mar 28, 2023Maxim GroupBuy—
Dec 9, 2021EF HuttonBuy—
Dec 3, 2020National SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network

The aim of HLH CRP is to bring respiratory season best practices to community pharmacies and improve access to protein-based vaccines, diagnostics and therapeutics targeting respiratory infectious diseases as cold and flu season begins across the U. Corexa Pharmacy in Lakeland, Florida will be the first pharmacy to roll out the program later in the fourth quarter of 2026.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By